Hepatitis C Elimination in the Netherlands

NCT04208035 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2019-12-23

No results posted yet for this study

Summary

The aim of CELINE is to retrieve and re-evaluate lost to follow-up chronic hepatitis C patients in the Netherlands.

Conditions

  • Chronic Hepatitis c

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY
  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Joost Drenth, MD, PhD · Radboud University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-17
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04208035 on ClinicalTrials.gov